Ciba forms development agreement with Biosignal.
Biosignal's anti-biofilm technology is based on a discovery that the eastern Australian seaweed Delisea pulchra produces natural furanones that disable bacteria's ability to colonize.
Development was expected to begin in May and testing will occur at Ciba's laboratories in Basel and Biosignal's facilities in Sydney.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Business & Industry|
|Date:||Jun 1, 2006|
|Previous Article:||Akzo Nobel makes bid for Sico Inc.|
|Next Article:||Smithers Group acquires Rapra Technology.|